MarketCapTrends
RCUS
Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare

Arcus Biosciences Inc. Cash on Hand 2017–2025

Arcus Biosciences Inc. annual/quarterly cash on hand history from 2017 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Arcus Biosciences Inc. cash on hand for the quarter ending December 31, 2025 were 222.0M, a 48.00% increase year-over-year.
  • Arcus Biosciences Inc. cash on hand for 2025 were 222.0M, a 48.00% increase from 2024.
  • Arcus Biosciences Inc. cash on hand for 2024 were 150.0M, a 18.11% increase from 2023.
  • Arcus Biosciences Inc. cash on hand for 2023 were 127.0M, a 38.35% decrease from 2022.
  • Arcus Biosciences Inc. cash on hand for 2022 were 206.0M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Arcus Biosciences Inc. Annual Cash on Hand (Millions of US $)
2025$222
2024$150
2023$127
2022$206
2021$148
2020$173
2019$58
2018$71
2017$98
Arcus Biosciences Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$222
2024-12-31$150
2023-12-31$127
2022-12-31$206
2021-12-31$148
2020-12-31$173
2019-12-31$58
2018-12-31$71
2017-12-31$98

Arcus Biosciences Inc. Cash on Hand — FAQ

Arcus Biosciences Inc. (RCUS) cash on hand over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RCUS's cash on hand history?

The chart and table above show Arcus Biosciences Inc.'s cash on hand by year and by quarter, including the growth rate.